Medacta Gains European Approval for Sports Medicine Products

Medacta has recently received CE marking for multiple sports medicine products: MectaLock PEEK instability anchors for hip and shoulder labral repair, MectaLock Ti and MectaTap for rotator cuff repair, MectaScrew PEEK interference screw for ligament repairs, Medacta Shoulder and Hip Cannula System, MectaQTH quadriceps tendon harvesting instrument and the Medacta Hip Access KIT for hip arthroscopies.

Medacta also has completed several first-time surgeries in the United States and Australia.
 
Over the last few weeks, Dr. Wesley Cox from Fayetteville, Ark., performed several glenoid labral repairs in the shoulder using Medacta’s MectaLock PEEK labral anchors. Dr. Cox is the first surgeon worldwide to use the Medacta instability anchor in shoulder labral repair.
 
After the introduction of the first hip labral repair surgeries in Australia with Dr. Parminder Singh using the Medacta MectaLock Peek Hip labral repair anchor, Dr. Michael B. Gerhardt performed the same surgery in Santa Monica, Calif., in December using Medacta’s complete hip portfolio. Dr. Gerhardt used Medacta’s MectaLock PEEK anchor together with MectaFlip Intra Articular Expander, Medacta Hip Cannula System and the newly launched Hip Access Kit. Dr. Gerhardt’s said after performing his first case with Medacta’s hip portfolio were: “Using Medacta’s new hip anchors and Mectaflip was a very positive experience. Congratulations to Medacta, I think we are building an excellent portfolio.”
 
On the other side of the globe, in Sydney, Australia, Dr. Bu Balalla performed an ACL reconstruction using Medacta’s Adjustable Button for the first time both on the femoral and tibial side. This was the first time the Adjustable Button had been used on the tibia. Earlier Adjustable Button surgeries on the femur had been carried out by Dr. Akbar Nawab of Louisville, Ky., and Dr. Matteo Denti of Lugano, Switzerland.
 
The launch of these new products and the recent first-time surgeries in the United States and Australia show Medacta’s commitment to continue developing its sports medicine portfolio, which consists of minimally invasive procedures aimed at allowing patients to return quickly to daily activities.